(RI) Pernod Ricard S.A. - Overview
Exchange: PA •
Country: France •
Currency: EUR •
Type: Common Stock •
ISIN: FR0000120693
Stock: Whiskey, Vodka, Gin, Rum, Liqueur
Total Rating 43
Risk 95
Buy Signal -0.46
Dividends
| Dividend Yield | 5.46% |
| Yield on Cost 5y | 3.51% |
| Yield CAGR 5y | 10.79% |
| Payout Consistency | 96.6% |
| Payout Ratio | 72.8% |
| Risk 5d forecast | |
|---|---|
| Volatility | 25.8% |
| Relative Tail Risk | -9.39% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.97 |
| Alpha | -30.08 |
| Character TTM | |
|---|---|
| Beta | 0.096 |
| Beta Downside | 0.069 |
| Drawdowns 3y | |
|---|---|
| Max DD | 62.61% |
| CAGR/Max DD | -0.40 |
Description: RI Pernod Ricard S.A. December 19, 2025
Pernod Ricard S.A. (ticker RI) is a Paris-based multinational that manufactures and distributes a broad portfolio of wines, spirits, and increasingly, non-alcoholic beverages. Its core alcoholic lineup spans whiskey, vodka, gin, rum, liqueur, tequila, mezcal, champagne and aperitif brands-including Chivas, Jameson, Absolut, Glenlivet, Martell, Havana Club, and Jacob’s Creek-while its zero-alcohol range features Beefeater 0% and Ceder’s among others.
Key recent metrics: FY 2023 revenue reached approximately €9.5 billion, with an adjusted operating margin of ~22 %, driven by a 8 % YoY increase in premium-segment sales and a 4 % rise in emerging-market volumes (particularly in Asia-Pacific). The sector’s growth is closely tied to global discretionary-spending trends, premiumization of consumer tastes, and regulatory pressure on alcohol advertising, which together shape demand elasticity and margin outlook.
For a deeper dive into Pernod Ricard’s valuation metrics and scenario analysis, check out the ValueRay profile.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 2.11b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA 0.97 > 1.0 |
| NWC/Revenue: 29.43% < 20% (prev 54.86%; Δ -25.43% < -1%) |
| CFO/TA 0.05 > 3% & CFO 1.84b > Net Income 2.11b |
| Net Debt (10.76b) to EBITDA (5.02b): 2.14 < 3 |
| Current Ratio: 1.92 > 1.5 & < 3 |
| Outstanding Shares: last fiscal year (252.0m) vs prev -0.46% < -2% |
| Gross Margin: 59.44% > 18% (prev 0.60%; Δ 5884 % > 0.5%) |
| Asset Turnover: 52.64% > 50% (prev 29.63%; Δ 23.01% > 0%) |
| Interest Coverage Ratio: 4.50 > 6 (EBITDA TTM 5.02b / Interest Expense TTM 973.5m) |
Altman Z'' 4.21
| A: 0.16 (Total Current Assets 12.36b - Total Current Liabilities 6.45b) / Total Assets 37.08b |
| B: 0.32 (Retained Earnings 11.77b / Total Assets 37.08b) |
| C: 0.11 (EBIT TTM 4.38b / Avg Total Assets 38.13b) |
| D: 1.29 (Book Value of Equity 26.98b / Total Liabilities 20.85b) |
| Altman-Z'' Score: 4.21 = AA |
Beneish M -2.90
| DSRI: 0.54 (Receivables 1.49b/1.60b, Revenue 20.07b/11.61b) |
| GMI: 1.01 (GM 59.44% / 59.93%) |
| AQI: 0.94 (AQ_t 0.52 / AQ_t-1 0.55) |
| SGI: 1.73 (Revenue 20.07b / 11.61b) |
| TATA: 0.01 (NI 2.11b - CFO 1.84b) / TA 37.08b) |
| Beneish M-Score: -2.90 (Cap -4..+1) = A |
What is the price of RI shares?
As of January 31, 2026, the stock is trading at EUR 75.60 with a total of 151,165 shares traded.
Over the past week, the price has changed by +0.11%, over one month by +3.48%, over three months by -8.62% and over the past year by -27.44%.
Over the past week, the price has changed by +0.11%, over one month by +3.48%, over three months by -8.62% and over the past year by -27.44%.
Is RI a buy, sell or hold?
Pernod Ricard S.A. has no consensus analysts rating.
What are the forecasts/targets for the RI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 97.8 | 29.4% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 66.5 | -12.1% |
RI Fundamental Data Overview January 28, 2026
Market Cap USD = 22.75b (19.00b EUR * 1.1978 EUR.USD)
P/E Trailing = 11.6961
P/E Forward = 12.0192
P/S = 1.7334
P/B = 1.2501
P/EG = 1.5638
Revenue TTM = 20.07b EUR
EBIT TTM = 4.38b EUR
EBITDA TTM = 5.02b EUR
Long Term Debt = 10.44b EUR (from longTermDebt, last quarter)
Short Term Debt = 1.81b EUR (from shortTermDebt, last quarter)
Debt = 12.59b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 10.76b EUR (from netDebt column, last quarter)
Enterprise Value = 29.76b EUR (19.00b + Debt 12.59b - CCE 1.83b)
Interest Coverage Ratio = 4.50 (Ebit TTM 4.38b / Interest Expense TTM 973.5m)
EV/FCF = 27.27x (Enterprise Value 29.76b / FCF TTM 1.09b)
FCF Yield = 3.67% (FCF TTM 1.09b / Enterprise Value 29.76b)
FCF Margin = 5.43% (FCF TTM 1.09b / Revenue TTM 20.07b)
Net Margin = 10.49% (Net Income TTM 2.11b / Revenue TTM 20.07b)
Gross Margin = 59.44% ((Revenue TTM 20.07b - Cost of Revenue TTM 8.14b) / Revenue TTM)
Gross Margin QoQ = 57.35% (prev 61.42%)
Tobins Q-Ratio = 0.80 (Enterprise Value 29.76b / Total Assets 37.08b)
Interest Expense / Debt = 1.83% (Interest Expense 231.0m / Debt 12.59b)
Taxrate = 23.38% (141.0m / 603.0m)
NOPAT = 3.36b (EBIT 4.38b * (1 - 23.38%))
Current Ratio = 1.92 (Total Current Assets 12.36b / Total Current Liabilities 6.45b)
Debt / Equity = 0.83 (Debt 12.59b / totalStockholderEquity, last quarter 15.21b)
Debt / EBITDA = 2.14 (Net Debt 10.76b / EBITDA 5.02b)
Debt / FCF = 9.86 (Net Debt 10.76b / FCF TTM 1.09b)
Total Stockholder Equity = 15.92b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.52% (Net Income 2.11b / Total Assets 37.08b)
RoE = 13.23% (Net Income TTM 2.11b / Total Stockholder Equity 15.92b)
RoCE = 16.62% (EBIT 4.38b / Capital Employed (Equity 15.92b + L.T.Debt 10.44b))
RoIC = 11.67% (NOPAT 3.36b / Invested Capital 28.76b)
WACC = 4.33% (E(19.00b)/V(31.59b) * Re(6.27%) + D(12.59b)/V(31.59b) * Rd(1.83%) * (1-Tc(0.23)))
Discount Rate = 6.27% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -0.25%
[DCF Debug] Terminal Value 88.43% ; FCFF base≈963.8m ; Y1≈1.19b ; Y5≈2.02b
Fair Price DCF = 191.4 (EV 58.96b - Net Debt 10.76b = Equity 48.20b / Shares 251.8m; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 2.77 | EPS CAGR: -53.79% | SUE: 0.0 | # QB: 0
Revenue Correlation: -7.70 | Revenue CAGR: 3.65% | SUE: N/A | # QB: 0
EPS current Year (2026-06-30): EPS=6.05 | Chg30d=-0.040 | Revisions Net=-7 | Growth EPS=-16.7% | Growth Revenue=-10.1%
EPS next Year (2027-06-30): EPS=6.23 | Chg30d=-0.070 | Revisions Net=-10 | Growth EPS=+2.9% | Growth Revenue=+0.8%
P/E Trailing = 11.6961
P/E Forward = 12.0192
P/S = 1.7334
P/B = 1.2501
P/EG = 1.5638
Revenue TTM = 20.07b EUR
EBIT TTM = 4.38b EUR
EBITDA TTM = 5.02b EUR
Long Term Debt = 10.44b EUR (from longTermDebt, last quarter)
Short Term Debt = 1.81b EUR (from shortTermDebt, last quarter)
Debt = 12.59b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 10.76b EUR (from netDebt column, last quarter)
Enterprise Value = 29.76b EUR (19.00b + Debt 12.59b - CCE 1.83b)
Interest Coverage Ratio = 4.50 (Ebit TTM 4.38b / Interest Expense TTM 973.5m)
EV/FCF = 27.27x (Enterprise Value 29.76b / FCF TTM 1.09b)
FCF Yield = 3.67% (FCF TTM 1.09b / Enterprise Value 29.76b)
FCF Margin = 5.43% (FCF TTM 1.09b / Revenue TTM 20.07b)
Net Margin = 10.49% (Net Income TTM 2.11b / Revenue TTM 20.07b)
Gross Margin = 59.44% ((Revenue TTM 20.07b - Cost of Revenue TTM 8.14b) / Revenue TTM)
Gross Margin QoQ = 57.35% (prev 61.42%)
Tobins Q-Ratio = 0.80 (Enterprise Value 29.76b / Total Assets 37.08b)
Interest Expense / Debt = 1.83% (Interest Expense 231.0m / Debt 12.59b)
Taxrate = 23.38% (141.0m / 603.0m)
NOPAT = 3.36b (EBIT 4.38b * (1 - 23.38%))
Current Ratio = 1.92 (Total Current Assets 12.36b / Total Current Liabilities 6.45b)
Debt / Equity = 0.83 (Debt 12.59b / totalStockholderEquity, last quarter 15.21b)
Debt / EBITDA = 2.14 (Net Debt 10.76b / EBITDA 5.02b)
Debt / FCF = 9.86 (Net Debt 10.76b / FCF TTM 1.09b)
Total Stockholder Equity = 15.92b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.52% (Net Income 2.11b / Total Assets 37.08b)
RoE = 13.23% (Net Income TTM 2.11b / Total Stockholder Equity 15.92b)
RoCE = 16.62% (EBIT 4.38b / Capital Employed (Equity 15.92b + L.T.Debt 10.44b))
RoIC = 11.67% (NOPAT 3.36b / Invested Capital 28.76b)
WACC = 4.33% (E(19.00b)/V(31.59b) * Re(6.27%) + D(12.59b)/V(31.59b) * Rd(1.83%) * (1-Tc(0.23)))
Discount Rate = 6.27% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -0.25%
[DCF Debug] Terminal Value 88.43% ; FCFF base≈963.8m ; Y1≈1.19b ; Y5≈2.02b
Fair Price DCF = 191.4 (EV 58.96b - Net Debt 10.76b = Equity 48.20b / Shares 251.8m; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 2.77 | EPS CAGR: -53.79% | SUE: 0.0 | # QB: 0
Revenue Correlation: -7.70 | Revenue CAGR: 3.65% | SUE: N/A | # QB: 0
EPS current Year (2026-06-30): EPS=6.05 | Chg30d=-0.040 | Revisions Net=-7 | Growth EPS=-16.7% | Growth Revenue=-10.1%
EPS next Year (2027-06-30): EPS=6.23 | Chg30d=-0.070 | Revisions Net=-10 | Growth EPS=+2.9% | Growth Revenue=+0.8%